Logo_AIHTA
  • Deutsch
  • Contact
    • Imprint
      • Privacy Notice
        • Newsletter
          • Sitemap
            Menu_button
            • News
              • About us
                • Research areas
                  • Research Projects
                    • Publications
                      • Search
                        • Announcements
                          • Events
                            • Newsletter
                              • Press release on our reports
                                • Press photos
                                  Video
                                  Video: What is HTA?    
                                  • Home
                                  • News

                                  News

                                  Leiste32


                                  Welcome to the homepage of AIHTA!

                                  AIHTA is an acadmic non-profit institute. At our website we wish to present our research and give support for health care decision-making. Here all of our reports are available for free. For further information please contact the AIHTA team.

                                  In the News section you will find our most recent publications: newsletter, project-reports etc. Previous reports you might find via Research areas, Research projects and Repository.

                                  Subscribe to newsletter

                                  Adobestock-386433869-von-andreas1
                                  ©stock.adobe.com

                                  Announcement

                                  National strategies and programmes for preventing and managing non-communicable diseases in selected countries

                                  Non-communicable diseases (NCDs) are the leading cause of death worldwide and are responsible for a high burden of disease. Many countries have developed national strategies for the management and prevention of NCDs in order to improve the care of chronically ill people or to prevent NCDs. This report aims to provide an overview of national NCD strategies from selected countries and their implementation as well as to summarise evaluation findings on specific programmes. The focus was on chronic respiratory and cardiovascular diseases, diabetes and depression.

                                  Publication: HTA Project Report No. 139:  https://eprints.aihta.at/1349/
                                  Contact: Lucia Gassner, Inanna Reinsperger

                                  More...

                                  Adobestock-206338397-elenabsl3
                                  ©stock.adobe.com

                                  Announcement

                                  Process and evaluation of digital health applications in the context of “symptom-checkers”

                                  Digital health applications (DiGAs) are increasingly using diagnostic and therapeutic algorithms. However, for the majority of currently available DiGAs, there is limited evidence on the medical or organizational benefit. Based on a suggested evaluation process for DiGAs outlined by AIHTA (Project report 2020: “Framework for reimbursement decisions of digital health technologies”), the proposed process for an evidence-based evaluation has been further refined and applied in a sample evaluation of a DiGA from the group of the so-called “symptom-checkers”.

                                  Publication: HTA Projekt Report No. 141: https://eprints.aihta.at/1348/
                                  Contact: Reinhard Jeindl

                                  More...

                                  2160
                                  ©stock.adobe.com

                                  Announcement

                                  Horizon Scanning in Oncology - Fact Sheets

                                  We are pleased to introduce our  new HSO Fact Sheet.

                                  Fact Sheet No. 71
                                  Sotorasib (Lumykras®): Sotorasib (Lumykras®) as monotherapy for the treatment of advanced NSCLC with KRAS G12C mutation

                                  More...

                                  Newsletter_preview

                                  Newsletter

                                  Note: this content is only available in German.

                                  Inhalt

                                  • Editorial: Offener Brief von ehemaligen Gesundheitsminister*innen (und vielen anderen Persönlichkeiten) zur Covid-19 Impfstoff-Patentfreigabe
                                  • Long-Covid Versorgungspfade: Eine systematische Übersichtsarbeit
                                  • Digitale Gesundheitsanwendungen: Symptom-Checker
                                  • Nationale Strategien und Programme zu Prävention und Management nicht-übertragbarer Krankheiten in ausgewählten Ländern
                                  • Spinraza®, Zolgensma® oder Kombinationstherapien: ein Update zu mittelfristiger Nachbeobachtung bei SMA Patient*innen
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  2159
                                  ©stock.adobe.com

                                  Announcement

                                  Horizon Scanning in Oncology - Fact Sheets

                                  We are pleased to introduce our four new HSO Fact Sheets.

                                  Fact Sheet No. 67
                                  Pembrolizumab (Keytruda) in combination with Lenvatinib (Kisplyx) for the firstline treatment of advanced renal cell carcinoma (RCC)

                                  Fact Sheet No. 68
                                  Pembrolizumab (Keytruda) in combination with Lenvatinib (Kisplyx) for the treatment of advanced or recurrent endometrial carcinoma (EC)      

                                  Fact Sheet No. 69
                                  Amivantamab (Rybrevant) as monotherapy for the treatment of patients with advanced non-small cell lung cancer (NSCLC)

                                  Fact Sheet No.  70
                                  Sacituzumab govitecan (Trodelvy) as monotherapy for the treatment of patients with unresectable or metastatic triple-negative breast cancer (mTNBC)

                                  More...

                                  Corona-virus5
                                  ©stock.adobe.com

                                  Announcement

                                  Covid-19: HSS/ Horizon Scanning Living Document (v18 October/November 2021)

                                  The establishment of a HSS/ Horizon Scanning System for Covid19 interventions has the intentions of informing health policy makers at an early stage which interventions (vaccinations and drugs) are currently undergoing clinical trials and to monitor them over the next few months in order to support evidence-based purchasing if necessary. The products are monitored with regard to the status of the clinical studies up to approval and finally evaluated for their benefit and harm.

                                  All work steps are conducted in close international (European) cooperation.

                                  Publications: 

                                  • Policy Brief No. 002: http://eprints.aihta.at/1234/

                                  Contact: Claudia Wild

                                  More...

                                  Adobestock-388026518-von-halfpoint4
                                  ©stock.adobe.com

                                  Announcement

                                  Long COVID care pathways: a systematic review

                                  Due to the expected growing number of long COVID cases and the associated increasing average sick leave durations, it not only places a burden on the patients and their families but also the wider economy, in particular, the workforce. The present systematic review aimed to support preparations and adjustments in the long COVID care planning in Austria by giving (1) an overview of recommendations about long COVID care pathways for adult patients as well as (2) examples of already existing care structures in selected European countries.

                                  Publlication: HTA Project Report No. 135b: https://eprints.aihta.at/1342
                                  Contact: Sarah Wolf

                                  More...

                                  Adobestock-240023632-von-christoph-burgstedt1
                                  ©stock.adobe.com

                                  Announcement

                                  Nivolumab in malignant melanoma: contrasting the evidence from the pivotal trials with the real world evidence (RWE)

                                  Nivolumab is an anti-PD1 checkpoint inhibitor used in patients with advanced malignant melanoma. The aim of this project was to evaluate the real world evidence from observational studies on Nivolumab for the treatment of malignant melanoma and to contrast the results with the evidence from pivotal RCTs. As a result of the comparison, there was good concordance between the outcomes of the included real-world studies and those of the pivotal RCTs across various lines of therapy, with slightly lower response rates.

                                  Publication: HTA Project report No. 140: https://eprints.aihta.at/1341
                                  Contact: Claudia Wild

                                  More...

                                  Newsletter_preview

                                  Newsletter

                                  Note: this content is only available in German.

                                  Inhalt

                                  • Editorial: Belgischer HTA Bericht analysiert Aufwand und Ergebnis von Onkologika in 12 Tumorerkrankungen (2004 – 2017)
                                  • Versorgungsforschung in der Onkologie: Immuntherapie bei NSCLC
                                  • Versorgungsforschung in der Onkologie: Nivolumab bei Melanom
                                  • DNA-Stuhltest zur Früherkennung von Darmkrebs – Update der Evidenz
                                  • Zweitmeinungen bei chirurgischen Verfahren
                                  • Termine
                                  • Themen-Vorschau
                                  Print Zur Druckversion...
                                  2158
                                  ©stock.adobe.com

                                  Announcement

                                  Horizon Scanning in Oncology - Fact Sheets

                                  We are pleased to introduce our five new HSO Fact Sheets.

                                  Fact Sheet No. 60
                                  Zanubrutinib (Brukinsa®) as monotherapy for the treatment of patients with waldenström’s macroglobulinaemia (WM)

                                  Fact Sheet No. 61
                                  Pralsetinib (Gavreto®) as monotherapy for the treatment of patients with rearranged during transfection (RET) fusion-positive advanced non-small cell lung cancer (NSCLC)

                                  Fact Sheet No. 62
                                  Ripretinib (Qinlock®) for the treatment of patients with advanced gastrointestinal stromal tumour (GIST)

                                  Fact Sheet No. 63
                                  Nivolumab (Opdivo®) in combination with fluoropyrimidine- and platinum-based combination chemotherapy for the treatment of patients with HER2?negative advanced or metastatic gastric, gastro?oesophageal junction or oesophageal adenocarcinoma

                                  Fact Sheet No. 64
                                  Pembrolizumab (Keytruda®) in combination with chemotherapy for the treatment of locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC)

                                  More...

                                  « < 1 2 3 4 5 ... > »
                                  Displaying results 21 to 30.
                                  • News
                                    • Announcements
                                      • Events
                                        • Newsletter
                                          • Press release on our reports
                                            • Press photos
                                            • About us
                                              • Evaluation
                                                • History
                                                  • Methods
                                                    • Team
                                                      • Shareholder & organization chart
                                                        • Stakeholder involvement
                                                          • Press clippings
                                                          • Research areas
                                                            • Oncology
                                                              • High tech medicine
                                                                • Rehabilitation and occupational therapy
                                                                  • Prevention and screening
                                                                    • Psychological & psychiatric interventions
                                                                      • Health economics
                                                                        • European collaboration
                                                                          • HTA-methods & steering instruments
                                                                            • Complementary medicine
                                                                            • Research Projects
                                                                              • Synopsis of current research projects
                                                                                • Synopsis of completed research projects
                                                                                  • Horizon Scanning in Oncology - Reports and Fact Sheets
                                                                                    • Horizon Scanning in Oncology – Prioritisation of new and emerging oncologic drugs
                                                                                      • Horizon Scanning in Oncology – support for a budget-impact-calculation
                                                                                        • Evaluation of individual medical procedures - Reports
                                                                                          • All projects in an overview
                                                                                          • Publications
                                                                                            • Repository
                                                                                              • HTA-Newsletter
                                                                                                • Annual Reports
                                                                                                • Search
                                                                                                  Netzwerk
                                                                                                  • Eunethta
                                                                                                  • Ebm
                                                                                                  • Inahta
                                                                                                  • Dexhelpp
                                                                                                  Shareholder
                                                                                                  • Bmfg
                                                                                                  • Sv
                                                                                                  • Wgfond
                                                                                                  • Noe
                                                                                                  • Ooghfond
                                                                                                  • Ghls
                                                                                                  • Tirol
                                                                                                  • Vorarlberg
                                                                                                  • Kghfond
                                                                                                  • Ghpf
                                                                                                  • Burgef
                                                                                                  • Contact
                                                                                                    • Imprint
                                                                                                      • Privacy Notice
                                                                                                        • Newsletter
                                                                                                          • Sitemap
                                                                                                            © 2022 HTA Austria - Austrian Institute for Health Technology Assessment GmbH. Alle Rechte vorbehalten.
                                                                                                            • Log in